TW252979B - - Google Patents
Info
- Publication number
- TW252979B TW252979B TW082109975A TW82109975A TW252979B TW 252979 B TW252979 B TW 252979B TW 082109975 A TW082109975 A TW 082109975A TW 82109975 A TW82109975 A TW 82109975A TW 252979 B TW252979 B TW 252979B
- Authority
- TW
- Taiwan
- Prior art keywords
- formula
- preparation
- image
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
- C07D457/12—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226967A GB9226967D0 (en) | 1992-12-24 | 1992-12-24 | Serotoninergic ergoline derivatives |
GB939305696A GB9305696D0 (en) | 1993-03-19 | 1993-03-19 | Scrotoninergic ergoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
TW252979B true TW252979B (zh) | 1995-08-01 |
Family
ID=26302231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW082109975A TW252979B (zh) | 1992-12-24 | 1993-11-26 |
Country Status (22)
Country | Link |
---|---|
US (1) | US5430031A (zh) |
EP (1) | EP0628042B1 (zh) |
JP (1) | JP3337688B2 (zh) |
KR (1) | KR100325274B1 (zh) |
CN (1) | CN1043230C (zh) |
AT (1) | ATE204278T1 (zh) |
AU (1) | AU669597B2 (zh) |
CA (1) | CA2125288C (zh) |
DE (1) | DE69330601T2 (zh) |
DK (1) | DK0628042T3 (zh) |
ES (1) | ES2162856T3 (zh) |
FI (1) | FI943839A (zh) |
HU (1) | HU220391B (zh) |
IL (1) | IL108085A (zh) |
MX (1) | MX9400165A (zh) |
NZ (1) | NZ258559A (zh) |
PL (1) | PL304893A1 (zh) |
PT (1) | PT628042E (zh) |
RU (1) | RU2131427C1 (zh) |
TW (1) | TW252979B (zh) |
UA (1) | UA41880C2 (zh) |
WO (1) | WO1994014806A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9407637D0 (en) | 1994-04-18 | 1994-06-08 | Erba Carlo Spa | Serotoninergic abeo-ergoline derivatives |
EP1685838A1 (en) * | 2000-08-16 | 2006-08-02 | Pharmacia & Upjohn Company LLC | Compounds for the treatment of addictive disorders |
MXPA03001472A (es) * | 2000-08-16 | 2003-06-06 | Upjohn Co | Compuestos para el tratamiento de trastornos adictivos. |
NZ530007A (en) * | 2001-06-08 | 2006-02-24 | Sod Conseils Rech Applic | Somatostatin-dopamine chimeric analogues that retain both somatostatin and dopamine activity in vivo and display enhanced biological activity |
SI21351A (sl) * | 2002-12-17 | 2004-06-30 | LEK farmacevtska dru�ba d.d. | Zdravljenje odvisnosti od psihostimulansov |
TWI523863B (zh) | 2012-11-01 | 2016-03-01 | 艾普森藥品公司 | 體抑素-多巴胺嵌合體類似物 |
CN104768565B (zh) | 2012-11-01 | 2017-04-26 | 益普生制药股份有限公司 | 促生长素抑制素类似物及其二聚体 |
CN106866656A (zh) * | 2017-02-28 | 2017-06-20 | 西南交通大学 | 一类麦角碱衍生物及其在预防和治疗精神疾病的用途 |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
CN114206349A (zh) | 2019-04-17 | 2022-03-18 | 指南针探路者有限公司 | 治疗神经认知障碍、慢性疼痛及减轻炎症的方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2802023A1 (de) * | 1977-01-28 | 1978-08-03 | Sandoz Ag | Neue ergotderivate, ihre herstellung und verwendung |
US4382940A (en) * | 1979-12-06 | 1983-05-10 | Farmitalia Carlo Erba S.P.A. | Ercoline derivatives and therapeutic compositions having CNS affecting activity |
GB8714767D0 (en) * | 1987-06-24 | 1987-07-29 | Erba Farmitalia | Egoline derivatives |
FI76085C (fi) * | 1981-07-21 | 1988-09-09 | Erba Farmitalia | Foerfarande foer framstaellning av ergolinderivat. |
CH649300A5 (de) * | 1981-08-07 | 1985-05-15 | Sandoz Ag | Ergopeptinderivate, ihre herstellung und verwendung. |
YU254782A (en) | 1981-12-18 | 1986-10-31 | Schering Ag | Process for making new ergot anilides |
DE3309493A1 (de) * | 1983-03-14 | 1984-09-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel |
PH21123A (en) * | 1983-04-28 | 1987-07-27 | Erba Farmitalia | Ergoline derivatives |
DE3445784A1 (de) * | 1984-12-13 | 1986-06-26 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Verfahren zur herstellung von ergolin-derivaten |
GB8501078D0 (en) * | 1985-01-16 | 1985-02-20 | Erba Farmitalia | Piperazin-1-yl-ergo-line derivatives |
GB8515528D0 (en) * | 1985-06-19 | 1985-07-24 | Erba Farmitalia | Ergoline derivatives |
DE3533672A1 (de) * | 1985-09-19 | 1987-03-26 | Schering Ag | Neue 12- und 13-substituierte ergolinderivate |
US4939258A (en) * | 1985-10-01 | 1990-07-03 | Eli Lilly And Company | Cycloalkanol esters of dihydrolysergic acid |
US4968802A (en) * | 1985-10-01 | 1990-11-06 | Eli Lilly And Company | Process of making alkoxy cycloalkanol esters of dihydrolysergic acid |
DE3535929A1 (de) * | 1985-10-04 | 1987-04-09 | Schering Ag | 1,2-disubstituierte ergolinderivate |
GB8612366D0 (en) * | 1986-05-21 | 1986-06-25 | Erba Farmitalia | Ergoline esters |
DE3620293A1 (de) * | 1986-06-16 | 1987-12-17 | Schering Ag | 1-und/oder 2-substituierte ergolinderivate |
DE3623438C2 (de) * | 1986-07-10 | 1998-04-09 | Schering Ag | In 2-Stellung mit radioaktivem Iod markierte Ergolinylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Diagnostika |
GB8702364D0 (en) * | 1987-02-03 | 1987-03-11 | Erba Farmitalia | Ergolinyl heterocycles |
US4931447A (en) * | 1987-06-15 | 1990-06-05 | Eli Lilly And Company | Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines |
US4843703A (en) * | 1987-07-07 | 1989-07-04 | Truth Incorporated | Method of assembling a window operator |
ES2032570T3 (es) * | 1987-11-20 | 1993-02-16 | Farmitalia Carlo Erba S.R.L. | Derivados antiparkinson de ergolina. (reserva del art. 167.2 cpe). |
DE3824659A1 (de) * | 1988-07-15 | 1990-02-08 | Schering Ag | 2-, 12- oder 13-substituierte 3-(8'(alpha)-ergolinyl)-1,1-diethylharnstoffe, ihre herstellung und verwendung in arzneimitteln |
GB8824744D0 (en) * | 1988-10-21 | 1988-11-30 | Erba Carlo Spa | Antiemesis ergoline derivatives |
US4902691A (en) * | 1988-12-19 | 1990-02-20 | Eli Lilly And Company | Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors |
DE3913756A1 (de) * | 1989-04-21 | 1990-10-25 | Schering Ag | 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung |
CA2049053A1 (en) * | 1990-01-25 | 1991-07-26 | Sergio Mantegani | Process for preparing ergoline derivatives |
-
1993
- 1993-11-26 NZ NZ258559A patent/NZ258559A/en unknown
- 1993-11-26 PT PT94901903T patent/PT628042E/pt unknown
- 1993-11-26 EP EP94901903A patent/EP0628042B1/en not_active Expired - Lifetime
- 1993-11-26 JP JP51472394A patent/JP3337688B2/ja not_active Expired - Fee Related
- 1993-11-26 AU AU56286/94A patent/AU669597B2/en not_active Ceased
- 1993-11-26 RU RU94040382A patent/RU2131427C1/ru not_active IP Right Cessation
- 1993-11-26 HU HU9401951A patent/HU220391B/hu not_active IP Right Cessation
- 1993-11-26 ES ES94901903T patent/ES2162856T3/es not_active Expired - Lifetime
- 1993-11-26 UA UA94085718A patent/UA41880C2/uk unknown
- 1993-11-26 DK DK94901903T patent/DK0628042T3/da active
- 1993-11-26 TW TW082109975A patent/TW252979B/zh active
- 1993-11-26 CA CA002125288A patent/CA2125288C/en not_active Expired - Fee Related
- 1993-11-26 PL PL93304893A patent/PL304893A1/xx unknown
- 1993-11-26 KR KR1019940702946A patent/KR100325274B1/ko not_active IP Right Cessation
- 1993-11-26 WO PCT/EP1993/003337 patent/WO1994014806A1/en active IP Right Grant
- 1993-11-26 DE DE69330601T patent/DE69330601T2/de not_active Expired - Fee Related
- 1993-11-26 AT AT94901903T patent/ATE204278T1/de not_active IP Right Cessation
- 1993-12-20 IL IL10808593A patent/IL108085A/en not_active IP Right Cessation
- 1993-12-20 US US08/169,177 patent/US5430031A/en not_active Expired - Fee Related
- 1993-12-23 CN CN93112788A patent/CN1043230C/zh not_active Expired - Fee Related
-
1994
- 1994-01-03 MX MX9400165A patent/MX9400165A/es unknown
- 1994-08-19 FI FI943839A patent/FI943839A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69330601D1 (de) | 2001-09-20 |
EP0628042A1 (en) | 1994-12-14 |
NZ258559A (en) | 1996-07-26 |
US5430031A (en) | 1995-07-04 |
MX9400165A (es) | 1994-07-29 |
PT628042E (pt) | 2002-01-30 |
JPH07504207A (ja) | 1995-05-11 |
PL304893A1 (en) | 1995-01-09 |
FI943839A0 (fi) | 1994-08-19 |
CN1043230C (zh) | 1999-05-05 |
RU2131427C1 (ru) | 1999-06-10 |
HUT68190A (en) | 1995-05-29 |
CN1093087A (zh) | 1994-10-05 |
HU9401951D0 (en) | 1994-09-28 |
IL108085A (en) | 1996-10-16 |
UA41880C2 (uk) | 2001-10-15 |
KR950700293A (ko) | 1995-01-16 |
EP0628042B1 (en) | 2001-08-16 |
AU669597B2 (en) | 1996-06-13 |
ES2162856T3 (es) | 2002-01-16 |
ATE204278T1 (de) | 2001-09-15 |
DE69330601T2 (de) | 2002-07-04 |
RU94040382A (ru) | 1996-07-10 |
CA2125288C (en) | 2004-11-23 |
DK0628042T3 (da) | 2001-11-12 |
WO1994014806A1 (en) | 1994-07-07 |
JP3337688B2 (ja) | 2002-10-21 |
IL108085A0 (en) | 1994-04-12 |
AU5628694A (en) | 1994-07-19 |
CA2125288A1 (en) | 1994-07-07 |
KR100325274B1 (ko) | 2002-08-14 |
FI943839A (fi) | 1994-08-19 |
HU220391B (hu) | 2002-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL124537A0 (en) | Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same | |
EP0482410A3 (en) | Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation | |
HU9302329D0 (en) | 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them | |
HU9302330D0 (en) | 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them | |
GR3031126T3 (en) | Taxol derivatives. | |
AU1608692A (en) | Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants | |
CA2076589A1 (en) | Naphthylethylureas and naphthylethylthioureas, the process for their preparation and pharmaceutical compositions holding same | |
PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
HRP940458B1 (en) | New bis-naphtalimides for the treatment of canser | |
TW252979B (zh) | ||
CA2219359A1 (en) | Hydantoin derivatives as intermediates for pharmaceutical active compounds | |
HU9202044D0 (en) | Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents | |
IL107232A0 (en) | 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
AU6187394A (en) | New pyrrolopyrazine compounds, processes for their preparation and the pharmaceutical compositions which contain them | |
ES2049186A1 (es) | Procedimiento para la preparacion de nuevos derivados de benzofuranil-imidazol. | |
HUT54682A (en) | Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds | |
HU9600300D0 (en) | Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these | |
ZA912535B (en) | Substituted 3-thia-and 3-oxa-alkylflavones,a process for their preparation,the use thereof,medicaments based on these compounds and intermediates | |
IL114646A0 (en) | Method of inhibiting leukotriene biosynthesis | |
HUT60495A (en) | Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds |